5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The UAE Patient Monitoring Equipment Market is segmented By Type of Device, By Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring), End User and Geography.
2018 - 2026
UAE Patient Monitoring Equipment Market is expected to register a CAGR of 1% during the forecast period. Some of the factors such as the rising burden of chronic diseases due to lifestyle changes, growth in the geriatric population, growing preference for home and remote monitoring, and ease of use and portability devices are propelling the market growth. Chronic diseases are the leading cause of death and disability in the United Arab Emirates. According to Institute for Health Metrics and Evaluation 2017, in the UAE the highest number of deaths was caused by cardiovascular diseases with around 7.35 million deaths reported in the year 2017. In addition, according to the same source mentioned above there around 13,736 cases of chronic obstructive pulmonary disease (COPD) in 2018. The numbers have been increased to 14,759 in 2019. Thus, the rising prevalence of chronic disorders will propel market growth.
Furthermore patient monitoring technologies identify small changes in the patient’s physiological data, hence promoting self-monitoring. Thus, it reduces readmissions and prevents avoidable hospitalizations, decreases the number of unnecessary trips to the doctor’s office and reduce travel-related expenses. On the short- and long-term basis, by the proper implementation, patient monitoring technologies can expand access to quality healthcare and save time and money.
As per the Scope patient monitoring devices are monitoring devices that continuously monitor the patient’s vital parameters, like blood pressure and heart rates, by using a medical monitor and collecting medical (and other) data from individuals.
|By Type of Device|
|Hemodynamic Monitoring Devices|
|Cardiac Monitoring Devices|
|Respiratory Monitoring Devices|
|Remote Patient Monitoring Devices|
|Other Types of Devices|
|Fetal and Neonatal|
|Weight Management and Fitness Monitoring|
|By End Users|
|Hospitals and Clinics|
|Other End Users|
Report scope can be customized per your requirements. Click here.
The key factors propelling the growth of this market are an increase in the number of critically ill geriatric cases, a rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems. According to the Global Health Data Exchange, there are around 455,632 new cases of cardiovascular diseases reported in UAE in the year 2019. The numbers have been increased from the past year(423,234). With the increasing prevalence of cardiovascular diseases and other chronic diseases in the United Arab Emirates, market growth also increases. Factors such as technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems further boost the segment growth.
Moreover, according to the Global Health Data Exchange, there is rising cases of Diabetes observed in the United Arab Emirates which is also positively impacting the see overall market growth.
To understand key trends, Download Sample Report
The UAE Patient Monitoring Equipment Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Abbott Laboratories, Baxter International Inc., Boston Scientific Corporation, Becton, Dickinson and Company, General Electric Company (GE Healthcare), Johnson & Johnson, , Medtronic Care Management Services LLC, Omron Corporation, Koninklijke Philips NV.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
4.2.2 Growing Preference for Home and Remote Monitoring
4.3 Market Restraints
4.3.1 Resistance from Healthcare Industry Professionals Toward the Adoption of Patient Monitoring Systems
4.3.2 High Cost of Technology
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type of Device
5.1.1 Hemodynamic Monitoring Devices
5.1.2 Neuromonitoring Devices
5.1.3 Cardiac Monitoring Devices
5.1.4 Multi-parameter Monitors
5.1.5 Respiratory Monitoring Devices
5.1.6 Remote Patient Monitoring Devices
5.1.7 Other Types of Devices
5.2 By Application
5.2.4 Fetal and Neonatal
5.2.5 Weight Management and Fitness Monitoring
5.2.6 Other Applications
5.3 By End Users
5.3.1 Home Healthcare
5.3.2 Hospitals and Clinics
5.3.3 Other End Users
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Baxter International Inc.
6.1.3 Boston Scientific Corporation
6.1.4 Becton, Dickinson and Company
6.1.5 General Electric Company (GE Healthcare)
6.1.6 Medtronic Care Management Services LLC
6.1.7 Omron Corporation
6.1.8 Koninklijke Philips NV
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments